INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2015

Green tea extract was generally tolerated but increased liver enzyme elevations

In a randomized trial, 1,075 postmenopausal women took daily green tea extract containing 843 mg epigallocatechin-3-gallate or placebo for one year. Overall adverse event rates were similar between groups (75.6% vs. 72.8%). However, the extract group experienced more nausea (P < 0.001) and significantly more alanine aminotransferase elevations (6.7% vs. 0.7%, P < 0.001), including 1.3% with serious related events.

Study type
Randomized, double-blind, placebo-controlled trial
Who was studied
1,075 postmenopausal women at risk for breast cancer
What was measured
Adverse events and liver enzyme elevations

THE PAPER

The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial.

Dostal AM, Samavat H, Bedell S, Torkelson C, Wang R, Swenson K, Le C, Wu AH, Ursin G, Yuan JM, Kurzer MS. Food Chem Toxicol, 2015.

PubMed 26051348 ↗DOI 10.1016/j.fct.2015.05.019 ↗

CancerFood safety & contaminants

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.